Jazz Securities Designated Activity Company
Summary
Jazz Securities Designated Activity Company is registered in Ireland and entered in the “Companies Register (CRO)” under number 562256. Its legal form is Designated Activity Company (DAC – (limited by shares)). According to GLEIF, its ultimate parent is Jazz Pharmaceuticals Public Limited Company (Ireland), which is also its direct parent. That group has 8 subsidiaries with LEIs in 4 countries, 5 of them in Ireland. The LEI was first issued on 13 Sep 2016 and the record was last updated on 31 Jul 2026; the next renewal is due by 13 Sep 2027. GLEIF's ISIN mapping lists 2 ISINs for this LEI. AssetCensus found 1 data-quality note for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2020, more than 24 months before this data release. The group may have changed since.
Company details
| Legal form | Designated Activity Company (DAC – (limited by shares)) |
|---|---|
| Register | Companies Register (CRO) · Register website |
| Registration number | 562256 |
| Registration authority | Companies Registration Office |
| Jurisdiction | Ireland |
| Registered address | Fifth Floor, Waterloo Exchange, D04 C5Y6 Dublin, Ireland |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 20 May 2015 |
| LEI | 6354009DV8VV7K6KOO02 |
| LEI status | active |
| LEI first issued | 13 Sep 2016 |
| LEI record last updated | 31 Jul 2026 |
| Next LEI renewal | 13 Sep 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | Jazz Pharmaceuticals Public Limited Company | Jazz Pharmaceuticals Public Limited Company |
| Accounting period | 1 Jan 2019 to 31 Dec 2019 | 1 Jan 2020 to 31 Dec 2020 |
| Evidence | consolidated accounts | consolidated accounts |
| Corroboration | fully corroborated | fully corroborated |
| Accounting standard | IFRS | IFRS |
| Relationship start | 1 Jan 2019 | 1 Jan 2020 |
| Recorded at GLEIF since | 9 Jul 2020 | 5 Aug 2022 |
| Last updated | 15 Sep 2025 | 15 Sep 2025 |
| Record status | current | current |
Other subsidiaries of the same direct parent (7)
ISINs mapped to this LEI (2)
US47216FAA57 · USG50882AA08
2 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.